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palavras-chave 
 
Biomarcadores no sangue, demência, diagnóstico, doença de Alzheimer, 
Fourier Transform Infrared Specctroscopy (FTIR), Infrared Spectroscopy.  
Resumo 
 
 
Atualmente, não é possível fazer um diagnóstico precoce e diferencial da 
doença de Alzheimer, deste modo, é necessário encontrar biomarcadores que 
o permitam. Para isso, os cientistas tentam encontrar um procedimento não-
invasivo, rápido, e relativamente barato. Os resultados de vários estudos 
demonstraram que a utilização de técnicas espectroscópicas, tais como a 
Espectroscopia de Infravermelho Transformada de Fourier (FTIR) e / ou 
espectroscopia de Raman, podem ser ferramentas úteis para diagnosticar a 
DA. Uma vez que, na DA, alguns mecanismos bioquímicos podem levar a 
mudanças em componentes do plasma, podem então ser utilizadas amostras 
de sangue nas análises espectroscópicas o que torna a técnica simples e 
menos invasiva.  
Com este trabalho pretende-se confirmar algumas das hipóteses de estudos 
anteriores em que o FTIR foi usado no estudo de amostras de plasma de 
possíveis doentes com DA e respetivos controlos e verificar a reprodutibilidade 
desta técnica espectroscópica na análise deste tipo de amostras. Através da 
análise espectroscopia  combinada com análise multivariada é possível  
discriminar as amostras controlos e dementes e identificar as principais 
diferenças espectroscópicas entre estes dois grupos de amostras que  
permitem identificar os metabolitos alterados nesta patologia. 
Pode-se concluir que existem três regiões espectrais, 3500-2700 cm
-1
, 1800-
1400 cm
-1
 e 1200-900 cm
-1
 onde se pode extrair informação espectroscópica 
relevante. Na primeira região, a principal conclusão que é possível tirar é que 
há um desequilíbrio entre o teor de lípidos saturados e insaturados. Na região 
entre 1800-1400 cm
-1
, é possível observar a presença de agregados de 
proteínas e a alteração na conformação das proteínas para folha β paralela 
altamente estável. A última região revelou a presença de produtos de 
peroxidação lipídica relacionados com a insuficiência de membranas, e danos 
oxidativos nos ácidos nucleicos. 
A técnica de FTIR e a informação reunida neste trabalho pode ser utilizada na 
construção de modelos de classificação que possam vir a ser utilizados para o 
diagnóstico de disfunções cognitivas. 
 
 
 
XII 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XIII 
 
 
  
 
 
 
 
 
 
  
Keywords 
 
Blood-based Biomarkers, Alzheimer’s disease, dementia, diagnosis, Fourier 
Transform Infrared Spectroscopy, infrared spectroscopy. 
 
Abstract 
 
Nowadays it is still difficult to perform an early and accurate diagnosis of 
dementia, therefore many research focus on the finding of new dementia 
biomarkers that can aid in that purpose. So scientists try to find a non-
invasive, rapid, and relatively inexpensive procedures for early diagnosis 
purpose. Several studies demonstrated that the utilization of spectroscopic 
techniques, such as Fourier Transform Infrared Spectroscopy (FTIR) and 
Raman spectroscopy could be an useful and accurate procedure to diagnose 
dementia. As several biochemical mechanisms related to neurodegeneration 
and dementia can lead to changes in plasma components and others 
peripheral body fluids, blood-based samples and spectroscopic analyses can 
be used as a more simple and less invasive technique. 
This work is intended to confirm some of the hypotheses of previous studies in 
which FTIR was used in the study of plasma samples of possible patient with 
AD and respective controls and verify the reproducibility of this spectroscopic 
technique in the analysis of such samples. Through the spectroscopic 
analysis combined with multivariate analysis it is possible to discriminate 
controls and demented samples and identify key spectroscopic differences 
between these two groups of samples which allows the identification of  
metabolites altered in this disease. 
It can be concluded that there are three spectral regions, 3500-2700 cm 
-1
, 
1800-1400 cm
-1
 and 1200-900 cm
-1
 where it can be extracted relevant 
spectroscopic information.  In the first region, the main conclusion that is 
possible to take is that there is an unbalance between the content of saturated 
and unsaturated lipids. In the 1800-1400 cm
-1 
region it is possible to see the 
presence of protein aggregates and the change in protein conformation for 
highly stable parallel β-sheet. The last region showed the presence of 
products of lipid peroxidation related to impairment of membranes, and 
nucleic acids oxidative damage.   
FTIR technique and the information gathered in this work can be used in the 
construction of classification models that may be used for the diagnosis of 
cognitive dysfunction. 
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Chapters overview 
 
 In chapter 1 there is a discussion about the differences between FTIR and FT-
Raman spectroscopy and a review about what have been done until now in the area of 
infrared spectroscopy and dementia diagnosis. This chapter was submitted as a review to 
the Journal of AD disease. 
Chapter 2 gives an overview of FTIR principles and it aims to discuss the intense 
water contribution in mid-infrared spectrum plasma samples, providing an optimized 
experimental methodology to overcome this problem. 
In chapter 3 will be presented and confirmed previous results on the application of 
FT-IR spectroscopy to the plasma samples of putative Alzheimer’s patients, and age and 
sex matched controls, in order to identify spectral differences that help discriminate 
between the two groups.  
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1. INTRODUCTION 
Diseases associated with age are prone to become increasingly prevalent. According to 
a WHO report, dementia contributed four 11,2% of the living years with a disability in 
people over 60 years old – more than stroke, cardiovascular disease and cancer [1–4]. 
Giving their pathological complexity, it is often difficult differential diagnosis of dementia 
in clinical practise, and to define landmarks that differentiate dementia from the mild 
decline in memory and cognitive function seen during ageing. The most common and most 
debilitating neurodegenerative disorder among the elderly is Alzheimer’s disease (AD), 
which is followed by frontotemporal lobar degeneration (FTLD), vascular dementia (VaD), 
dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) [5,6]. 
Nowadays, the available clinical diagnosis criteria used to identify dementia allows 
to detect pathologies in a very advanced stage of disease, when is too late for any kind of 
successful disease adjustment. Further, an early and accurate diagnosis of dementia 
enables detection of potentially treatable disorders that contribute to cognitive 
impairment, such as depression, vitamin deficiencies and hypothyroidism [7]. It is sorely 
needed a simple, accurate and cost-effective early diagnosis for dementia in order to treat 
and even prevent first signs of disease, with introduction of reliable therapeutic 
approaches (e.g. disease-modifying therapies). This becomes possible with the innovative 
and different approaches in research that focus on novel dementia biomarkers 
identification and validation [8,9]. 
Metabolomic techniques have been used to identify biochemical pathways 
alterations linked to several diseases, either in biological fluids (plasma, urine and CSF – 
cerebrospinal fluid), animal models and tissue or cell cultures [10]. Since it allows to 
identify and/or quantitate the metabolites in a given biological sample, using unbiased 
metabolomics approach could provide a more complete picture of dementia pathology [8]. 
The main metabolic fingerprinting techniques for disease diagnosis includes infrared (IR) 
and Raman spectroscopy, which can provide details of chemical composition and 
molecular structure of analysed samples. Diseases and other pathological anomalies lead 
to chemical and structural alterations at the molecular level that also change the 
vibrational spectra. These spectral changes can be used as sensitive and phenotypic 
markers of disease, constituting a specific and unique real fingerprint [11,12].   
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2. POTENTIAL OF BLOOD-BASED BIOMARKERS 
CSF represents the most suitable biological fluid to study neurodegenerative diseases 
since it can reflect the biochemical changes occurring in brain, although its analysis is not 
always feasible for a large scale screening, because of the huge economic costs and 
invasive procedures, uncomfortable and not without risk. Besides, CSF is not amenable for 
repeated sampling that is an important aspect in the perspective of biomarker's role and 
utility in disease diagnosis and therapeutics. In the other hand, blood-based biomarkers 
are minimally invasive and could increase diagnostic accuracy, be useful for prognosis and  
monitoring of therapeutic interventions [13].  
It is important to note that only small hydrophobic, lipophilic molecules are more 
easily transported from CSF into blood, through blood-brain barrier (BBB). This implies that 
the most relevant markers will be in low abundance in plasma, at least in normal healthy 
people. Nevertheless, there is increasing evidence for a compromised BBB in 
neurodegeneration, which will impact on the type of molecules leaking out of brain into 
blood circulation [2].   
One of the main metabolomics challenges for using this approaches in clinical practise 
is the development of standard protocols regarding sample collection and storage, 
chemical analyses, data processing, and information exchange. Indeed, it was already 
created the Metabolomics Standard Initiative (MSI), supported by the Metabolomic 
Society, to recommend standard protocols for use in all aspects of metabolomic research 
[14]. Besides, extensive standardization of several aspects of biomarkers analysis is now 
being addressed through the international quality-control program, which includes CSF 
reference materials, in the European Joint Programming project “Biomarkers for 
Alzheimer’s disease and Parkinson’s disease” (BIOMARKAPD) [15,16]. Work to validation of 
both fluid-based and imaging biomarker thresholds is also ongoing [17]. 
Since peripheral sources of biomarkers, like blood, are further away from the brain, 
this implies that peripheral markers will need to be correlated with accepted markers of 
dementia present in brain tissue and CSF, to demonstrate that these can also reflect 
dementia pathology [2]. Likewise it is necessary to determine whether these biomarkers 
can be influenced by other organ systems, since demented patients also typically present 
comorbidities due to normal ageing process [18].  
Other challenge in biomarkers research is the substantial overlap of major brain 
pathologies, therefore, a better understanding of how combinations of pathologies affect 
changes in biomarkers is needed [7]. Powerful and innovative bioinformatics tolls will be 
needed to unravel multivariate plasma disease signatures [2]. 
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3. METABOLOMICS AS A NOVEL APPROACH IN NEW 
DEMENTIA BIOMARKERS RESEARCH 
Metabolomics is an emerging field in development that started to be recently applied  
as a non-targeted approach to neurodegenerative disorders biomarkers discovery. 
Metabolomics is now commonly defined as the detection and quantitation of all low-
molecular-weight molecules and metabolites present in cells, tissues or organisms under a 
set of given conditions [2,11,19]. The metabolome is the collection of small molecules that 
are found within a biological system and whose identities, concentrations and fluxes are 
the final product of interactions between gene and protein expression, and the cellular 
environment. Thus, metabolomics information complements the obtained data from 
genomics, transcriptomics and proteomics [6].  
A typical metabolomic study includes four main steps: representative sample 
collection, sample analysis (e.g. FTIR, nuclear magnetic resonance - NMR, mass 
spectrometry - MS), statistical analysis (e.g. principal component analysis - PCA, Partial 
Least Squares- Discriminant analysis - PLS-DA) and identification of significantly altered 
metabolites that could be translated into new disease biomarkers/pathways, with 
generation of a disease metabolic fingerprinting [4]. The main metabolic fingerprinting 
approaches used for disease diagnostics includes IR and Raman spectroscopy, NMR and 
MS-based methods [20].  
Vibrational spectroscopy has been proposed as a reagent-free and non-destructive 
approach towards tackling the traditional problems associated with biofluids in diagnosis 
and screening [21]. FTIR has a significant and ongoing history of research into its potential 
as a diagnostic tool and allows for the extremely rapid, high-throughput and non-
destructive analysis of a wide range of sample types. Although FTIR has been previously 
recognized as not as specific and sensitive as some of the MS-based techniques, the 
reproducibility of FTIR has been demonstrated through the extensive number of the 
published research using this technology. Besides, it has been recognized as a valuable tool 
for metabolic fingerprinting as it is able to simultaneously analyse carbohydrates, amino 
acids, fatty acids, lipids, proteins, nucleic acids and polysaccharides with a minimum 
amount of sample preparation. Also, FTIR is less expensive and more accurate rather other 
methods [11,22]. As a complimentary tool to IR spectroscopy, Raman spectroscopy is also 
non-destructive, non-contact and reagent-free. Since Raman is a scattering technique and 
thus it is not perturbed by aqueous, it potentially allow in vivo and live-cell imaging. 
Besides, it has recently been shown that by using centrifugal filter devices to concentrate 
analytes, an enhanced signal-to-noise ratio (SNR) can be achieved [21].  
Apart from several analytical procedures that result in quantitative data, for diagnostic 
purposes it is  important  to  define  some  categorical  differentiable  classes  for  the  
obtained  data,  most commonly  by  dividing  samples  in  healthy  or  disease  affected  
classes.  This important area of chemometric data processing is called classification, whose 
main aims are pattern recognition and discrimination analysis. Multivariate analysis uses 
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mathematical, statistical and computer sciences to efficiently extract useful information 
from data generated via chemical measurements [23,24]. Multivariate classification 
techniques can be further divided into two categories: unsupervised and supervised 
learning procedures. In this first category, it is not required an a priori knowledge about 
training set samples (i.e. the class membership of the training samples), therefore, 
samples will be grouped into a number of classes with certain communalities without 
initial qualification of samples and their class assignment. Examples of unsupervised 
methods are PCA and cluster analysis (CA). Hence, unsupervised patter-recognition 
techniques are exploratory methods for data analysis, which seek inherent similarities of 
data. Using this method, unexpected grouping within a training sample set that might not 
be initially evident may be discovered, e.g. that a group of disease samples might be 
additionally separated into two or more distinctly different classes [24,25].    
 
4. VIBRATIONAL SPECTROSCOPY: PRINCIPLES AND 
APPLICATIONS 
Spectroscopy has recently arised as one of the major tools for biomedical applications 
and has made significant progress in the field of clinical evaluation. The vibrational 
spectroscopic techniques are relatively simple, reproducible, non-destructive to the 
samples and requires a minimum sample preparation process, with small amounts of 
biological material (micrograms to nanograms) to spectroscopy analysis [26]. It is 
important to note that when the drying process is applied to the liquid samples (e.g. 
plasma), as a method to minimize water signals in spectra, samples restore is impossible 
after spectroscopic analysis; hence, in this case, vibrational spectroscopy has a destructive 
nature for samples.    
In contrast to other blood products as serum, plasma exhibits a good metabolite 
concentrations reproducibility, which may result from the simple collecting procedure for 
plasma, as it does not require time to coagulate [27]. Removal of cellular component from 
blood, in order to obtain plasma, allows to exclude perturbations of the chemical analysis 
or to ensure that blood cells metabolism does not interfere with metabolite concentration 
values. This latter point is particularly important for glucose identification, since its 
concentration begins to decrease immediately after sampling due to the glycolytic action 
of erythrocytes and leucocytes [28]. 
These techniques provide information at the molecular level that allows investigation 
of functional groups, bonding types, and molecular conformations. Spectral bands in 
vibrational spectra are molecule specific and provide direct information about the 
biochemical composition of a given sample, since these bands are relatively narrow, easy 
to resolve, and sensitive to molecular structure, conformation and environment. Spectral 
peaks can be often associated with vibration of a particular chemical bond or a single 
functional group in the molecule [26].  
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Although Raman spectroscopy and FTIR are relevant techniques with their respective 
spectra complementary to one another, the two methods differ in the physical mechanism 
(Table 1), showing specific advantages for biological applications [12], [29].  
Table 1| Principal technical differences between FTIR and Raman spectroscopy. Adapted from [29]. 
 
Instrumentation is thus typically less complex for IR (absorption of radiation) than 
for Raman (light scattering). Besides IR data collection is usually faster, often leading to 
higher SNR than those obtained through Raman. In the other hand, aqueous systems can 
only be analysed by IR spectroscopy if samples of few micrometre thickness are prepared 
(for tissue samples) or if attenuated total reflection (ATR) measurements are performed 
[12]. ATR-FTIR spectroscopy may cover a relatively large sampling area, which makes it an 
ideal technique for cytology as large numbers of cells can be studied at given time, 
becoming easier to identify a small number of atypical cells. Also, since dispersion effects 
are weaker in ATR-FTIR, there are fewer spectral artefacts. This makes from ATR-FTIR a 
very applicable method to the routine monitoring of biofluids [21].   
IR spectral region (Figure 1) ranges from the red end of visible spectrum at 780 nm 
(12820 cm-1 of wavenumber) to the onset of microwave region at a wavelength of 1 mm 
(10 cm-1). In turn, IR range is further subdivided into the near-infrared (NIR), mid-infrared 
(MIR) and far-infrared (FIR) regions. MIR covers the range 4000-400 cm-1 and is the region 
that usually provides the fingerprint characteristics of molecular species, especially at 
1500-600 cm-1 (fingerprint region). Raman spectroscopy generates bio-fingerprint spectra 
within the 2000-400 cm-1 region, and it is based on inelastic light scattering of 
monochromatic light from a laser in the visible, NIR or near-ultraviolet regions [21], [30].  
 FTIR Raman 
Type of samples mainly non-aqueous both aqueous and non-aqueous 
Main analysis 
troubles 
strong absorption bands of water fluorescence and strong effect of glass 
Sample preparation more than Raman Minimal 
Confocal imaging cannot perform can perform 
Physical effect 
changes in dipole moment during 
molecular vibration 
(dipole and ionic bands) 
change in polarizability 
(covalent bands) 
Resolution lateral: 1-2 μm; confocal: 2,5 μm lateral: 10-20 μm 
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 Figure 1|The electromagnetic spectrum, with IR region magnified. Adapted from [31], [32]. 
 
Protein misfolding and aggregation are present at a range of neurodegenerative 
diseases, including certain forms of dementia such as AD and PDD, whereby a secondary 
structure change of specific proteins into β-sheet enriched conformations occurs. FTIR is 
also a powerful tool to determine such secondary structure alterations, which can 
potentialy be used as diagnostic markers. Given the challenge of secondary structure 
analysis of a specific protein within a complex body fluid, it was developed a novel ATR-
FTIR based immune-sensor, whose main element is an ATR-flow-through cuvette equipped 
with a germanium crystal as an internal reflection element. This cuvette is covered with a 
quartz-window that allows parallel control-measurements by fluorescence spectroscopy. 
According to Nabers et al. 2015 that developed this methodology using Aβ peptide, the 
sensor has to be optimized with a highly-specific Aβ-antibody (process of sensor surface 
modification). Nevertheless, it is a new hope for label-free diagnostics in complex body 
fluids [33].  
Ultimately, it will be needed an easy-to-use analytical tool, using validated 
classification or biomarker analysis system, allowing for on-the-spot repeat measurements 
at minimal cost. Such a microfluidic device would only require a small aliquot of blood, 
which could be separated into plasma or serum; directed to independent ATR diamonds, a 
spectral reading could then be remotely classified giving an answer within minutes or 
seconds. Hence, monitoring of emerging disease, it would likewise open doors for a more 
personalized medicine [21].         
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5. FT-RAMAN AND FTIR  APPLIED TO DEMENTIA 
DIAGNOSIS 
Some studies have been conducted using FTIR and FT-Raman supporting the use of 
these techniques in the diagnosis of certain dementias. Promising results have been 
obtained with different groups reporting similar data as summarized below. 
The results obtained by P. Carmona et al. 2012, using FTIR, about the amide I band 
mean spectra shows differences in the 1640–1625 cm−1 range, the local where protein β - 
amyloid can be detected, between the group of controls and the group of patients with 
moderate AD. In this range, it was detected an increase in the intensity of the AD spectrum 
at 1631 cm−1 and 1638 cm−1, the first one related to the development of amyloid β-sheet 
structures and the second to the β-sheet proteins, which generate amide I vibrational 
modes clustering. Another peak at 1683 cm−1 was also related to the β-sheet structure and 
all these differences can be evidence that AD can be related with oxidative stress. Auto-
peak at 1730 cm−1 was associated to carbonyl absorption; the auto-peaks appearing near 
1656 and 1665 cm−1 can be related to α-helices and turns, respectively; and the auto-peak 
at 1642 cm−1 demonstrate that those structures can change to β-sheet and/or unordered 
structure [34]. 
Another study of P. Carmona et al. 2013 that compares the controls and moderate AD 
samples, using Raman spectroscopy, showed an increase in the intensity at 1672 cm−1 and 
a decrease at 1658 cm−1. The increase at 1672 cm-1 could be caused by β-sheet-rich 
proteins or peptides such as Aβ1-40 and Aβ1-42. In AD samples an increase in the intensity of 
the 409 cm-1 band comparing with controls could also be observed. This band was likewise 
associated with Aβ1-40 and Aβ1-42 peptides. The authors correlate the decrease in the 
intensity at 1658 cm−1 with a decrease in the intensity at 980-910 cm−1 in the AD spectrum, 
proposing that this could be related to α-helices. In the map of the FTIR spectroscopy it 
was observed two correlated peaks, the strongest at 1635 cm−1 and another at 1690 cm−1, 
these peaks are related to protein β-sheets. About the tertiary structure of the proteins 
the results showed alterations in the AD spectral range at 780–730 cm−1, associated with 
an increase of band intensity near 758 cm−1 and other near 743 cm−1. The first one caused 
by the indole ring-breathing vibration of tryptophan residues and the second band is due 
to the in-phase benzene CH out-of-plane bending vibration. The map of FTIR can also 
indicate markers of oxidative stress in AD. In this report an auto-peak ranging from 1120 to 
1000 cm−1, one at 1235 cm−1 and other at 1295 cm−1 correlating to oxidative stress signal 
were observed. The cause of the first one can be the C-O stretching vibrations, while the 
second one is caused by protein β-sheets and both are correlated, the third peak is 
negatively correlated with the second because it is attributed to α-helices [35]. 
An additional study by E. Ryzhikova et al. 2014, appling Raman technique, that could 
differentiate AD from healthy controls showed 7 different regions (13 bands). The first 
region was located at 400–467 cm-1 and exhibit three different bands (at 415, 419 and 455 
cm-1), corresponding to proteins, lipids, carbohydrates, phosphatidylinositol and 
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phosphoenolpyruvate. The second region was located at 505–523 cm-1, and presented 
bands at 509, 519 and 526 cm-1, related to proteins, carbohydrates, coenzyme A, 
phosphatidylinositol, phosphatidylserine, acetoacetate and glutathione. The third region 
was located at 993–1011 cm-1, with one band at 1003 cm-1 correlated to proteins, 
carbohydrates and acetoacetate. The fourth region, located at 1030–1049 cm-1 was 
represented by two bands at 1031 and 1050 cm-1 that corresponds to proteins, 
carbohydrates, fatty acids, phosphoenolpyruvate and coenzyme A. The fifth region was 
located at 1218–1237 cm-1 and has two bands (at 1207 and 1235 cm-1) related to proteins 
and pyruvate. The sixth region wwas located at 1444–1462 cm-1, the band identified was 
located at 1448 cm-1 and was correlated to proteins, fatty acids, carbohydrates, 
phosphoenolpyruvate, acetoacetate, β-carotene and glutathione. The seventh region was 
located at 1537–1556 cm-1 with one band at 1553 cm-1 that was related to guanine, 
tryptophan, proline, palmitic acid and N-acetylglucosamine [36]. 
Further, P. Chen, Q. Tian, et al. 2011 reported that the Raman spectra exhibited two 
principal differences between the spectra of the controls and the spectra of two AD 
models (4-month and 12-month old AD transgenic mice), namely at 740 and 1654 cm−1.  
The first peak showed an increased in intensity, comparing the controls with the AD mice, 
which could be probably caused by alterations in the amyloid precursor protein ratio 
(APPr). The peak at 1654 cm-1 presented a decrease in the intensity that was probably 
related to amide I band of the protein α-helix structure [37].  
 Regarding in dementia diagnosis, of E. Peuchant et al. 2008, reported three regions 
that could help in AD diagnosis. One is located at 1480 – 1140 cm-1 and presented six 
peaks: 1455 cm-1, due to the CH2 bending vibrations of mainly fatty acids; 1402 cm
-1 
related to the COO- symmetric vibrations of amino acid side chains and fatty acids; 1343 
and 1315 cm-1, correlated to the CH2 side chain vibrations in lipids and proteins; 1242 and 
1155 cm-1, caused by the asymmetric phosphate stretching vibrations and by the 
stretching vibration of the CO group of the nucleic acid ribose. A region between 1140 and 
1095 cm-1 were three peaks at 1128, 1119 and 1105 cm-1 were observed are linked to the 
phosphate stretching vibrations of the phosphodiester backbone and the stretching 
vibrations associated with the CO group of deoxyribose. Another peak was associated with 
the CO stretching vibrations in deoxyribose/ribose of nucleic acids at 1053 cm-1. Third 
region was located between 1020 and 930 cm-1 and five peaks, related to the CO 
stretching vibrations in osidic acid and protein structures and to the symmetric stretching 
mode of dianionic phosphate monoester of nucleic acids, were detected at 1012, 994, 987, 
970, and 936 cm-1 [38].  
Additional, results of some IR spectroscopy studies of isotopically labeled Aβ10–35′ 
and Aβ40 showed an amide I band maximal at 1658 cm
−1 for unlabeled or 13C-labeled 
forms of Aβ40, the results are similar for unlabeled or labeled forms of Aβ10–35´. For 
unlabeled Aβ10–35′ and Aβ40 after aggregation the amide I band is maximal at 1624 cm
−1 and 
has a high frequency shoulder at 1685 cm−1. PATIR-FTIR (polarized attenuated total 
internal reflection-FTIR) spectra of Aβ42 on monolayer membranes made from 100% 
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DMPC (dimyristoyl phosphatidylcholine) or oxidatively damaged SAPC (1-stearoyl-2-
arachidonyl phosphatidylcholine) revealed a common feature in both membranes at 
∼1623 cm−1 and probably due to membrane-adsorbed Aβ42 in a β-sheet conformation. 
Another component at ∼1650 cm−1, that was less evident, indicates that some of the 
adsorbed protein has a helical or random coil structure. The conclusion of these data was 
that Aβ42 acquire an antiparallel β-structure induced by an oxidized damaged membrane. 
The IR spectroscopy it was also used to study the capacity of Aβ42 to seed fibril formation 
by Aβ40 and it was observed that this ability of Aβ42 only occurs on membranes 
containing oxidatively damaged SAPC [39].  
Concerning the results of the aforesaid study of E. Ryzhikova et al., at 
differentiating AD from other types of dementia, were obtained 9 regions of interest (30 
bands), as described in (Table 2). 
Table 2|Raman spectral regions and bands of interest, with respective sample contents. Adapted from [36]. 
Regions Bands Sample contents 
410–672 cm
-1
 
415, 419, 455, 477, 509, 519, 
526, 545, 567, 585, 605, 621, 
643 and 662 cm
-1
 
proteins, lipids, carbohydrates, riboflavin, 
phosphatidylinositol and phosphoenolpyruvate 
710–784 cm
-1
 718, 744 and 757 cm
-1
 
proteins,  phospholipids, phosphatidylcholine, 
phosphoenolpyruvate, acetoacetate, coenzyme A, 
acetyl coenzyme A, D-fructose-6-phosphate, 
riboflavin and glutathione 
973–1010 cm
-1
 1003 cm
-1
 proteins, carbohydrates and acetoacetate 
1086–1122 cm
-1
 1083, 1104 and 1126 cm
-1
 
proteins, carbohydrates, acetyl coenzyme A, 
acetoacetate, D-fructose-6-phosphate, 
phosphoenolpyruvate and phospholipids 
1199–1235 cm
-1
 1207 and 1235 cm
-1
 proteins and pyruvate 
1311–1348 cm
-1
 1317 and 1338 cm
-1
 
Proteins, carbohydrates, phosphoenolpyruvate, 
glutathione and phospholipids 
1424–1498 cm
-1
 1448 cm
-1
 
proteins, fatty acids, carbohydrates,  
phosphoenolpyruvate, acetoacetate, β-carotene 
and glutathione 
1537–1611 cm
-1
 1553 and 1586 cm
-1
 
guanine, tryptophan, proline, lysine, palmitic acid 
and N-acetyl –glucosamine 
1649–1800 cm
-1
 1657 cm
-1
 proteins, amide I, α-helix and phospholipids 
 
Raman and NIR spectroscopy are also used to study other types of dementia, such 
as PDD, Schipper, Kwok, Rosendahl et al 2008. For Raman spectroscopy it was observed an 
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increase in the alcoholic (R-OH) and nitrogenous (N-H) scatter bands at 3330 and 3200 cm-
1, respectively, also accompanied by the detection of a decrease in the hydrocarbon (C-H) 
scatter at 2990 cm-1, comparing the controls with the PD patients. This technique aided in 
PDD diagnose with a specificity of 72% and a sensitivity of 74%. The results obtained for 
NIR were similar with the ones mentioned before; a band at 700 nm corresponds to 
background, one at 830 nm related to C-H, one at 942 nm due to R-OH, one at 983 nm 
correlated to water vibrations and one at 1014 nm due to N-H [40]. 
One of the applications of NIR spectroscopy is in the analyses of some changes in 
the concentrations of oxy-hemoglobin (HbO), deoxy-hemoglobin (HbR) and total-
hemoglobin (HbT). To study these changes in patients with Subcortical VaD the 
researchers combined two techniques NIR spectroscopy and fMRI (functional magnetic 
resonance imaging). With these hemodynamic results it was possible to evaluate cerebral 
blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) in individuals with 
Subcortical VaD. The Study showed a decrease in CMRO2, CBF and in flow-metabolism 
coupling ratio and an increase in the oxygen extraction fraction (OEF)  [41].  
 
6. FTIR ANALYSIS  OF BLOOD-BASED SAMPLES 
As mentioned, direct analysis of an FTIR spectra (Figure 2), permits the identification of 
the maximum wavenumber peaks. Each of these spectral signals have one or more 
assignment (specific type of molecular vibration), that corresponds to a certain chemical 
group and/or chemical family of compounds. This correspondence allows to establish a 
specific chemical pattern of analysed samples, with identification of the main chemical 
components (Table 3). Figure 2 represents the model spectra of a plasma sample, at 4000-
600 cm-1 region, showing maximum wavenumber peaks obtained in this study, the 
samples were dried.  
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Figure 2| FTIR model spectra of a plasma sample, at 4000-600 cm
-1
 region, showing maximum wavenumber peaks. 
The downer picture is a magnification of the 1800-900 cm
-1
 spectral region acquired from the first spectra, showing 
also maximum wavenumber peaks. X-axis: wavenumber (cm
-1
); Y-axis: arbitrary units (A.U.) 
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Table 3| Maximum wavenumber peaks founded in FTIR spectra and its main assignments and correspondents 
plasma contents. 
Peaks 
(cm
-1
) 
Assignments Plasma contents Ref. 
≈ 3718 
O-H stretching and an intermolecular  
vibration of CO2 and phenol** 
Presence of gaseous CO2  [42] 
≈ 3454 N-H stretching Proteins (amide A) [43] 
≈ 3286 
N-H stretching, H-O-H symmetric and 
asymmetric stretching*  
Proteins (amide A) 
[44], [45] 
≈ 3190 N-H symmetric stretching mainly cis-ordered sub-structures [26] 
≈ 3052 N-H stretching Proteins (amide B) [26] 
≈ 2962 
C-H asymmetric stretching of CH3 
group* 
Lipid acyl chains in lipid bilayers 
(phospholipids) 
[29], [44], 
[46], [47] 
≈ 2938 
C-H stretching of CH2 and CH3 group* Fatty acids [29], [43], 
[44] 
≈ 2878 
C-H symmetric stretching of CH3 
group* 
Lipid acyl chains in lipid bilayers 
(phospholipids) 
[29], [44], 
[46], [47] 
≈ 1740 
C=O stretching Fatty acid esters (triglycerides), 
lipid bilayers (phospholipids) 
[23], [44], 
[46] 
≈ 1716 
C=O stretching Carbonic acid, phospholipid sub-
structures, purine bases from 
nucleic acids 
[23], [29], 
[44], [48] 
≈ 1638 
C=O stretching*;  
NH3
+
 asymmetric in plane bending 
(rocking)* 
Proteins (amide I for β-sheet); 
Membrane lipids (phospholipids) 
[29], [44], 
[47], [49] 
≈ 1536 
N-H bending in plane, C-N stretching* Proteins (amide II) [29], [44], 
[45] 
≈ 1512 
CC (phenyl ring) stretching, CH in plane 
bending*  
tyrosine band (proteins side chain)  [29], [44], 
[50] 
≈ 1470 
CH2 bending;  
C-H asymmetric bending;  
CH2 symmetric in plane bending 
(scissoring)* 
Proteins; 
Carbohydrates;  
Lipid acyl chains in lipid bilayers 
(phospholipids) 
[23], [26], 
[29], [47] 
≈ 1452 
CH2 bending and CH3 asymmetric in 
plane bending (rocking)*; 
C-O symmetric stretching 
Proteins, membrane lipids 
(phospholipids); 
Carbohydrates 
[23], [26], 
[46], [47] 
≈ 1398 
C=O symmetric stretching of COO
-
 
group, C-O symmetric stretching*; 
C-O bending (carboxylate ions)*; 
CH3 and N
+
(CH3)3 symmetric bending* 
Proteins and carbohydrates; 
Mixed region (carboxylic groups); 
Membrane lipids (phospholipids) 
[23], [45]–
[47] 
≈ 1338 CH2 wagging*  Membrane lipids (phospholipids) [45], [47] 
≈ 1320 C-O stretching Carbohydrates [23] 
≈ 1290 
N-H bending in plane, C-N stretching*; 
C-O stretching; 
N-H thymine/cytosine deformation 
Proteins (amide III); 
Carbohydrates; 
Nucleic acids  
[23], [26], 
[44], [45] 
≈ 1242 
N-H bending in plane, C-N stretching*; 
P=O asymmetric stretching of PO2
-
 
group 
Proteins (amide III, mainly α-helix 
conformation); 
Phosphodiester groups of nucleic 
acids 
[26], [44], 
[45] 
≈ 1168 
Ester and CO-O-C antisymmetric 
stretching*;  
C-O, C-C stretching and C-O-H, C-O-C 
deformation* 
Membrane lipids (phospholipids); 
Carbohydrates [44], [45], 
[47] 
≈ 1115 
C-O, C-C stretching, C-O-H, C-O-C 
deformation and C-O-C asymmetric 
stretching*; 
Carbohydrates;  
Phosphodiesters, RNA 
[23], [26], 
[44] 
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P-O-C symmetric stretching, C-O 
stretching of C-OH group 
≈ 1077 
C-O, C-C stretching, C-O-H, C-O-C 
deformation and C-O-C asymmetric 
stretching*; 
PO2
-
, CO-O-C symmetric stretching*; 
Carbohydrates; 
Membrane lipids (phospholipids) 
and nucleic acids sugar backbone  
 
[23], [26], 
[44], [47] 
≈ 1032 
C-O, C-C stretching, C-O-H, C-O-C 
deformation*; 
C-O symmetric stretching 
Carbohydrates; 
Nucleic acids sugar backbone 
[23], [26], 
[44] 
≈ 987 
C-O, C-C stretching, C-O-H, C-O-C 
deformation, C-H bending*; 
CH3-N asymmetric stretching 
Carbohydrates; 
Membrane lipids (phospholipids) [23], [44] 
≈ 924 
C-O, C-C stretching, C-O-H, C-O-C 
deformation*; 
N
+
(CH3)3 symmetric stretching*  
Carbohydrates; 
Membrane lipids (phospholipids) [44], [47] 
*Characteristic band assignments of biological samples (not specific for plasma) 
**Not characteristic of biological samples 
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7. CONCLUDING REMARKS 
Regarding the handling of some biofluids, such as blood, challenges remain to 
overcome. One of these challenges is the development of a reliable, standardized and 
marketable test for assessing the AD blood biomarkers. It is necessary that this test can be 
applied into standard clinical practise; whereat definitive clinical trials are needed to 
define their true diagnostic value [21,51].  
A particular attractive item in focus in the last decade is combination of different 
spectroscopic techniques, such as FTIR and FT-Raman, for analysis of complex biological 
samples (e.g. body fluids and tissues). This arise the  challenge of computer-based pattern 
recognition techniques elaboration, capable of providing effective data reduction and 
optimal classification results, from spectral data of samples collected in all IR regions. 
Possible candidates for this kind of data process/analysis pass through modern neural 
network (ANN) analysis strategies and effective optimal-feature extraction algorithms [29].     
In the future it will be also necessary to apply FTIR and/or FT-Raman in samples of 
different stages of dementia, such the case of AD, to confirm if the spectra changes along 
disease progression. It could be also helpful compare the results of neuroimaging 
techniques and the spectra data. [35] 
Recently, an immunologic ATR-FTIR sensor was used to study the secondary structure 
change of the Aβ peptide to β-sheet in early stages of AD, this can be helpful in the 
diagnosis of the disease. This ATR sensor removed Aβ peptide out of fluids (e.g. blood or 
CSF), and FTIR was subsequently applied to analyse Aβ secondary structure [33]. A new 
door opened for the application of vibrational spectroscopic techniques in dementia 
research, namely at discovering new, non-invasive and reliable biomarkers. 
Finally, since diagnosis of multifactorial dementias cannot rely on a unique marker, the 
use of a combination of different biomarkers is of extremely importance. In addition, 
comparison of metabolic and proteomic profiles within the same disease and between 
different forms of dementia can significantly, increase the specificity of the new 
biomarkers, thus contributing to a more accurate and differential diagnosis.  [52, 53] 
8. AIMS OF THE STUDY 
 
The main objectives of the present work are: 
 
 Confirm some  hypotheses of previous studies by FTIR; 
 Identify  the main metabolic characteristics present in obtained FTIR spectra; 
 Discriminate samples in groups (e.g. control vs AD) through data multivariate 
analysis and confirm the location of the samples on the scores diagram; 
 Identify the more significant altered metabolites and their eventual role at the 
disease context. 
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1. INFRARED SPECTROSCOPY 
 Infrared spectroscopy is a technique based on the vibrations of the atoms of a 
molecule that can be very useful because can give information about the purity of a 
compound and about its structure. In the electromagnetic spectrum there are several 
radiation regions, the radiation visible to the human eye, radiowave, microwave, infrared, 
ultraviolet, X-ray and γ-ray. Infrared radiation is used in infrared spectroscopy and is a kind 
of radiation that is absorbed by different materials. In the electromagnetic spectrum the 
infrared is localized between the visible and microwave regions. The basic principle of this 
technique is when an organic molecule is exposed to infrared radiation the radiant energy 
matches the energy of a specific molecular vibration, absorption occurs. A plot that shows 
the absorption of infrared radiation against the wavelength of infrared radiation is called 
infrared spectrum. The instrument used to obtain the infrared spectrum is IR spectrometer 
and the way that is obtained is: the infrared radiation pass through the sample and then 
the fraction of the incident radiation that is absorbed at a particular energy is determined, 
which will result in the identification (qualitative analysis) of the materials. The peaks of 
energy observed in the absorption spectrum correspond to the frequency of a vibration of 
a part of a molecule of the sample and their size give information about the amount of 
material present. The only material from which it is not possible to observe an infrared 
spectrum is metal and the sample can be in any state solid, liquid or gaseous, what is an 
advantage because it allows the utilization of infrared spectroscopy in different areas. 
Some substances that absorb infrared radiation are powder, glass, crystals, solutions, 
pastes, films, liquids, fibres and vapours. The areas that use this technique most are 
materials science, life science and surface science and the samples are in the majority in 
the solid or liquid state. [51-55] 
 The major difference between the visible absorption spectra and the infrared 
absorption spectra is that in the first spectra (visible) it is only possible to observe one or 
two broad bands and in the second (infrared) it is possible to see many and quite sharp 
bands, for example organic compounds have a considerable number of infrared absorption 
bands. The cause of this difference is that the infrared absorptions are due to vibrational 
sates of atoms in a molecule, so infrared spectrum is a vibrational spectrum and the 
motions of atoms in the molecule are named molecular vibrations; in contrast the visible 
absorption spectrum is an electronic spectrum because it is related to the states of 
electrons in a molecule. [51] 
In an infrared spectrum the ordinate axis matches to the absorption intensity and 
the abscissa axis matches to the wavelength but there is a particularity in the mid-infrared 
region, sometimes it is used the wavenumber as an alternative to wavelength in the 
abscissa axis. The wavenumber is the inverse of wavelength and is the number of light 
waves per unit length, the units in which is expressed are cm -1. In the case of near-infrared 
region the wavelength is frequently used as the abscissa axis when the near-infrared 
spectrum is measured as an extension of a visible absorption spectrum. [51, 55] 
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 The spectral measurements and the spectrum are made with the aim of determine 
a signal, the signal is the quantity of radiation absorbed, reflected or emitted by the 
sample, the signal is generally represented by S. But when someone obtains a signal it also 
obtains a noise that can come from different sources, the noise can be represented by a N. 
In a spectrum is also possible to rate it quality, for that it is necessary to determine the 
signal-to-noise ratio (S/N ratio, SN ratio or SNR) of the bands; the quality of the spectrum 
is higher when the signal-to-noise ratio is higher. [51] 
 Molecules have molecular vibrations and molecular rotations that are discreet 
energy levels of electronic motions. When molecules absorb energy they suffer a 
transition from a lower energy state to a higher energy state, for example when a 
molecule is irradiated by electromagnetic waves which may diverge from ultraviolet light 
to microwaves it occur a transition. But the transition has to fulfil some conditions such as: 
• “The energy of a photon should coincide with the energy difference between an 
energy level of the molecule (usually the ground-state level) and a higher energy level (an 
excited-state level).” [51, 55] 
 There are also other rule called selection rule that are based in quantum 
mechanics and group theory and these rule say that to occur infrared absorption the 
molecule must have a specific aspect:  an electric dipole moment of the molecule must 
change during the vibration, so there are “infrared-active” molecules (i.e. heteronuclear 
diatomic molecule) and “infrared-inactive” molecules (i.e. homonuclear diatomic 
molecule). In the case of infrared-active molecules the dipole moment of a molecule 
changes as the bond expands and contracts in contrast in the infrared-inactive molecules 
its dipole moment remains zero no matter how long the bond.  [51, 53, 55] 
 Transitions between the energy levels of molecular vibrations are what lead to 
infrared absorptions mostly. Then it is possible to say that the vibrational spectra are 
constituted by infrared absorption spectra, Raman spectra and neutron inelastic scattering 
spectra. [51] 
There are “pure” vibrational spectra that is an infrared spectra observed from 
liquids and solids because in these kind of samples free rotation of molecules does not 
occur. On the contrary the infrared absorption spectra observed from gases are vibration-
rotation spectra because in that spectrum it is possible to detect some fine structures that 
are result of the transitions associated with rotational energy levels. [51] 
 Infrared radiation is absorbed by the molecule when the dipole moment of a 
molecule is changed due to a molecular vibration, and the radiation absorbed has the 
same frequency as the molecular vibration, due that this process of infrared absorption 
happen by electric interaction of molecules with infrared radiation. The absorption of 
infrared radiation by the molecule leads to the transition of it from the v=0 (ground 
vibrational state) to v=1 (first excited vibrational state) and this process is named the 
fundamental tone. Although less likely to happen the transition could be from v=0 to 
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v=2,3,4…, in these cases it is called overtones but the intensity of these absorptions are 
weaker than in the first case. If the transitions are between excited vibrational states it is 
denominated hot bands, but usually they are not seen. [51] 
1.1. Types of infrared radiation  
 The infrared radiation can be divided into three types depending on the 
wavelength: near, mid and far infrared radiation. It is commonly defined the wavelength of 
0.78 µm to 3 µm (12820 – 4000 cm-1) for near-infrared region; 3 µm to 30 µm (4000 – 400 
cm -1) for mid-infrared region; and 30 µm to 300 µm (400 – 33 cm-1) for far-infrared region. 
[51, 52, 53, 55] 
  1.1.1. Near-infrared region 
 In the near-infrared region it is observed the overtones or combinations of the 
fundamental stretching bands which occur in the 3000–1700 cm−1 region and the bands 
involved are result of C–H, N–H or O–H stretching. In this region the intensity of the bands 
is generally weak.  [53] 
  1.1.2. Mid-infrared region 
 The mid-infrared region is the region that usually can give more information and it 
may be identified four different regions: the X–H stretching region (4000–2500 cm−1), the 
triple-bond region (2500–2000 cm−1), the double-bond region (2000–1500 cm−1) and the 
fingerprint region (1500–600 cm−1). O–H, C–H and N–H stretching are responsible for the 
fundamental vibrations in the region of 4000-2500 cm-1; the triple-bond absorptions are 
due to the high force constants of the bonds such as C≡C bonds or C≡N bonds; in the third 
region (2000-1500 cm-1) the C=C and C=O stretching lead to the principal bands. The 1500-
600 cm-1 region is called the “fingerprint region” because some vibrations may vary by 
hundreds of wavenumbers and it is what happens in this region where small steric or 
electronic effects in the molecule lead to large shifts, so the majority of the bands are not 
assigned and the spectrum works as a “fingerprint” of the molecule. [53] 
  1.1.3. Far-infrared region 
 The far-infrared region can give some information about the vibrations of 
molecules containing heavy atoms, molecular skeleton vibrations, molecular torsions and 
crystal lattice vibrations. Crystal lattice vibrations are result of the movement of whole 
molecular chains with respect to each other in crystalline solids; the molecular torsions 
occur because the rotation about single bonds is not “free”, so when certain small groups 
are bonded to a large group, they undergo a motion with respect to the heavier “anchor” 
group; bending modes are usually no more than one-half of the wavenumber of the 
corresponding stretching mode, thereby in far-infrared region skeletal bending modes 
involving an entire molecule occur for molecules containing heavier atoms; in the case of 
the vibrations involving heavy atoms they can be useful for characterizing compounds 
containing halogen atoms, organometallic compounds and inorganic compounds. [53] 
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2. MOLECULAR VIBRATIONS 
 When a molecule interacts with infrared radiation changes in molecular dipoles 
associated with vibrations and rotations occur. The larger this change, then the more 
intense will be the absorption band. The energy of a molecule in a specific moment is the 
result of the sum of the following energy terms, electronic energy, vibrational energy, 
rotational energy and translational energy. Electronic energy is associated with the energy 
transitions of electrons as they are distributed throughout the molecule, either localized 
within specific bonds, or delocalized over structures, such as an aromatic ring. Vibrational 
energy is linked to the absorption of energy by a molecule as the component atoms 
vibrate about the mean center of their chemical bonds. Rotational energy is defined as the 
tumbling motion of a molecule, which is due to the absorption of energy within the 
microwave region. Translational energy is associated to the displacement of molecules in 
space as a function of the normal thermal motions of matter. [53, 55, 56] 
 Diatomic molecules have two degrees of rotational freedom, three degrees of 
translational freedom and one of vibrational freedom. The atoms of polyatomic molecules 
have 3 degrees of freedom, which correspond to the Cartesian coordinates (x, y, z) of each 
atom in the molecule. There are two types of triatomic molecules: linear and non-linear. 
Non-linear molecules have 3 rotational and 3 translational degrees of freedom, the 
remaining (3n-6) correspond to fundamental vibrations. Linear molecules have 2 degrees 
of rotational freedom and 3 of translational freedom, therefore in this situation the 
remaining fundamental vibrations are 3n-5. [52, 53] 
 In a molecule the bond length of the atoms can vary or they can move out of its 
present plane, it corresponds to stretching (axial deformation - Change in inter-atomic 
distance along bond axis) and bending (angular deformation - Change in angle between 
two bonds), that are collectively referred as vibrations. There are two different types of 
stretching, symmetric stretching and asymmetric stretching (figure 3). About bending it is 
possible to distinguish four different types, rocking, scissoring, wagging and twisting 
(figure 4). [52, 53, 55, 57] 
 
 
Figure 3| Symmetric and asymmetric stretching vibrations. [53] 
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Figure 4| Different types of bending vibrations. [53] 
 
Diatomic molecules have only one mode of vibration, a stretching motion. A linear 
polyatomic molecule has four modes, two of which have the same frequency and non-
linear polyatomic molecules have three modes, one is due to a bending motion and the 
other two correspond to stretching motions. [53] 
 It is not possible to isolate the motion of two atoms in a molecule from the motion 
of the rest of the atoms in the molecule. One atom can be shared by two oscillating bonds 
and when this happens it is said that the vibrations of the two bonds are coupled. The 
result is that if one bond contracts, the other bond will contract or expand, depending if is 
an asymmetrical or symmetrical stretching. In coupling, in place of superimposed bands as 
expected, are observed bands at different frequencies. There are some factors that can 
influence coupling: in stretching vibrations coupling occurs when there is a common atom 
between two vibrating bonds; bending vibrations coupling occurs if there is a common 
bond between vibrating groups; if coupling is between a stretching vibration and a 
bending vibration occurs if the stretching bond is one side of an angle varied by bending 
vibration; if coupled groups have roughly equal energies the coupling is greatest; there is 
no coupling between groups separated by two or more bonds. [52, 57] 
 
3. COMPLICATING FACTORS 
There are some factors that can influence and difficult the analyses of an infrared 
spectrum, called complicating factors, sometimes they can lead to important changes to 
the spectra and may result in the misinterpretation of bands, some of them are: 
3.1. Overtone and combination bands:  
 
Combination bands are the result of the absorption of energy simultaneously for two 
bands absorbing at ν1 and ν2. Overtone bands are analogous and are multiples of the 
fundamental absorption frequency. The energy necessary for the first overtone is the 
double of the energy required in the fundamental and the first overtone will appear in the 
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spectrum at twice the wavenumber of the fundamental because the energy is proportional 
to the frequency absorbed and this is proportional to the wavenumber (figure 5). [53] 
 
 
Figure 5| Energy levels for fundamental and overtone infrared bands. [53] 
 
3.2. Fermi Resonance:  
Sometimes it is possible that two bands appear in the place where only one is 
supposed to appear, for example when an overtone or a combination band has the same 
frequency as, or a similar frequency to, a fundamental. This is the Fermi resonance effect 
and it is stronger when the frequencies match. [53] 
3.3. Coupling:  
 
Vibrations in the skeletons of molecules become coupled and that vibrations involve a 
large part of the carbon backbone and oxygen or nitrogen atoms. The result is the same 
number of vibrational modes, but at different frequencies, and bands can no more be 
ascribed to one bond. Coupling is more likely to occur in C–C stretching, C–O stretching, C–
N stretching, C–H rocking and C–H wagging motions. [53] 
 
 
3.4. Vibration-Rotation bands:  
Like explained before the gaseous heteronuclear molecules have a specific spectrum 
and to examine the length of one bond it is necessary to separate the lines that appear in 
the spectrum. [53]  
 
4. FOURIER TRANSFORM INFRARED SPECTROSCOPY  
 One type of infrared spectroscopy is FTIR that is a global, sensitive, and highly 
reproducible physicochemical analytical technique that identifies structural moieties of 
biomolecules on the basis of their IR absorption. FTIR can help to identify unknown 
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materials, can determine the quality or consistency of a sample and can determine the 
amount of components in a mixture.  Some advantages of FTIR are: 
• The measurements obtained with this technique are very accurate and 
reproducible; 
• It is a very reliable technique for positive identification of virtually any sample; 
• It is very sensitive allowing the identification of even the smallest of contaminants 
then can be used for quality control or quality assurance; 
• The sensitivity and accuracy of the detectors and a wide variety of software 
algorithms increased the practical use of infrared for quantitative analysis. [54, 58] 
 
4.1. Fourier-Transform Infrared Spectrometers 
In the past, since the 1940s were used dispersive instruments to obtain infrared 
spectra, nowadays the spectrometers used are the Fourier-transform infrared 
spectrometers (Michelson Interferometers are the most used) which enhanced the 
acquisition of infrared spectra. Some advantages of instruments used currently over the 
older instruments are: 
• Is a non-destructive technique; 
• Provides a precise measurement method which requires no external calibration; 
these instruments employ a HeNe laser as an internal wavelength calibration 
standard so they are self-calibrating - Connes Advantage;  
• Can increase speed, collecting a scan every second because all of the frequencies 
are measured simultaneously - Felgett Advantage; 
• Sensitivity can be improved: the detectors are much more sensitive and the optical 
throughput is much higher which results in much lower noise levels - Jacquinot 
Advantage; 
• Fast scans enable the co-addition of several scans in order to reduce the random 
measurement noise to any desired level - signal averaging; 
• Is mechanically simple with only one moving part, the moving mirror in the 
interferometer is the only continuously moving part in the instrument. [54] 
The principal components of a Fourier-transform Infrared Spectrometers (figure 6) 
are the source, the interferometer, the sample, the detector, the amplifier, the analog-to-
digital converter and a computer. [53, 54] 
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Figure 6| Schematic representation of a Michelson interferometer, showing the principal components. [53] 
The first step of a FTIR analysis is the infrared energy is emitted from the source, 
and the beam passes through an aperture which controls the amount of energy presented 
to the sample and after to the detector. The source used in FTIR spectrometers depends 
on the region that it will be examined. For near-infrared region the source used is 
tungsten-halogen lamps; for the mid-infrared region the source used is a Globar or Nernst 
source; for the far-infrared region it is necessary to use a high-pressure mercury lamp. [53, 
54] 
After that the beam enters the interferometer where the “spectral encoding” takes 
place. Michelson interferometers are composed of two perpendicularly plane mirrors, one 
of which can travel in a direction perpendicular to the plane, one is a flat mirror which is 
fixed in place, the other is a flat mirror which is on a mechanism which allows this mirror 
to move a very short distance (typically a few millimetres) away from the beamsplitter. 
The beamsplitter is a semi-reflecting film that bisects the planes of the two mirrors. 
According to the region that is necessary analyse, mid-, near-, or far-infrared region the 
material used in the beamsplitter is different. For the mid- or near-infrared regions some 
of the materials used are germanium or iron oxide coated onto an ‘infrared-transparent’ 
substrate such as potassium bromide or caesium iodide. In the far-infrared region the 
materials used are thin organic films like poly (ethylene terephthalate). When an 
accurately parallel beam of monochromatic radiation passed into an ideal beamsplitter 
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50% of the incident radiation will be reflected to one of the mirrors and the other 50% will 
be transmitted to the other mirror. After that the two beams are reflected and return to 
the beamsplitter to recombine and interfere. The beamsplitter transmit 50% of the beam 
reflected from the fixed mirror and the remaining 50% is reflected back in the direction of 
the source. The beam that will be detected in FTIR spectrometry is called the transmitted 
beam and emerges from the interferometer at 90° to the input beam. [53, 54] 
When evaluating an infrared spectrum there are several factors related with the 
moving mirror that is need to be considered, for example it has to be accurately aligned 
and must be capable of scanning two distances so that the path difference corresponds to 
a known value. The transformation of the digitized information on the interferogram into a 
spectrum can lead also to some errors because the transformation carried out in practice 
involves an integration stage over a finite displacement rather than over an infinite 
displacement and the mathematical process of Fourier transformation assumes infinite 
boundaries. Another source of error arises if the sample intervals are not exactly the same 
on each side of the maxima corresponding to zero path differences. [53] 
Posteriorly the transmitted beam enters the sample compartment, where can be 
transmitted through or reflected off of the surface of the sample. It is here where the 
sample will absorb specific frequencies of energy that are unique of that sample. [53, 54] 
The subsequent step is the passage of the beam to the detector for final 
measurement. It is not only the source that it is different according to the region, the 
detectors used in FTIR spectrometers is also different from region to region. To analyse a 
near-infrared region it is used lead sulphide photoconductors detectors; for the mid-
infrared region two types of detectors can be used, the most common is a pyroelectric 
device incorporating tryglycine sulphate (DTGS) in a temperature-resistant alkali halide 
window and if it is needed a more sensitive analysis the detector used is a mercury 
cadmium telluride (MCT) cooled to liquid nitrogen temperatures; for far-infrared region 
the detectors used are, germanium or indium–antimony detectors, operating at liquid 
helium temperatures. [53, 54] 
Finally the measured signal is digitized and sent to the computer where the Fourier 
transformation takes place to obtain the infrared spectrum. Computer has a number of 
functions in the modern infrared instruments. Some of those functions are: 
• Controls the instrument: it sets scan speeds and scanning limits, and starts and 
stops scanning; 
• It reads spectra into the computer memory from the instrument as the spectrum is 
scanned; 
• Spectra may be manipulated using the computer: by adding and subtracting 
spectra or expanding areas of the spectrum of interest; 
• Scan the spectra continuously and average or add the result in the computer 
memory; 
• Plot the spectra. [53, 54] 
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When a FTIR analysis is done is also necessary to measure a background spectrum, 
which is a measurement with no sample in the beam and one background measurement 
can be used for many samples. This measurement is needed because there needs to be a 
relative scale for the absorption intensity and then is compared to the measurement with 
the sample in the beam to determine the “percent transmittance”. This allows detecting 
the spectral features strictly due to the sample. [53, 54] 
4.2. ATR (Attenuated Total Reflectance Spectroscopy) 
 ATR (Attenuated Total Reflectance spectroscopy) is a technique that utilizes the 
phenomenon of total internal reflection. A beam of radiation entering a crystal will 
undergo total internal reflection when the angle of incidence at the interface between the 
sample and crystal is greater than the critical angle, where the latter is a function of the 
refractive indices of the two surfaces. The beam penetrates a fraction of a wavelength 
beyond the reflecting surface. The beam will lose energy at the wavelength where the 
material absorbs when a material that selectively absorbs radiation is in close contact with 
the reflecting surface. The resultant attenuated radiation is measured and plotted as a 
function of wavelength by the spectrometer and gives rise to the absorption spectral 
characteristics of the sample. The depth of penetration in ATR spectroscopy is a function 
of the wavelength, λ, the refractive index of the crystal, n2, and the angle of incident 
radiation, θ. The depth of penetration of the evanescent wave into the sample is a 
function of the crystal material and the angle of incidence. Deeper penetration is achieved 
with either a smaller incidence angle or a lower refractive index crystal. The depth of 
penetration also increases with the wavelength. [53, 59]  
The most common material used in the crystals used in ATR cells are zinc selenide 
(ZnSe), germanium (Ge) and thallium–iodide (KRS-5) because those are materials that have 
low solubility in water and are of a very high refractive index.  Zinc Selenide is a relatively 
low cost ATR crystal material and is ideal for analysing liquids and non-abrasive pastes and 
gels but it is not particularly robust with a working pH range of 5-9. Germanium has a 
much better working pH range and can be used to analyse weak acids and alkalis. 
Germanium has by far the highest refractive index of all the ATR materials available which 
means that the effective depth of penetration is approximately 1 micron. Although having 
a higher cost, diamond is the best ATR crystal material because of its robustness and 
durability. Diamond can be used to analyse a range of samples from single particles and 
fibbers to corrosive liquids. [53, 59, 60] 
There are different designs of ATR cells which allow the analysis of liquid and solid 
samples. It is possible monitor the spectral changes for the continuous flow of solutions 
through the cell with time because it is possible to set up a flow-through ATR cell by 
including an inlet and outlet in the apparatus. [53] 
 Some of the advantages of ATR are: 
• Faster sampling; 
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• Improving sample-to-sample reproducibility;  
• Minimizing user to user spectral variation; 
• Better quality database building for more precise material verification and 
identification. [60] 
 
5. MID-INFRARED SPECTROSCOPY APPLIED IN 
BIOLOGICAL SAMPLES 
 Human plasma and serum are commonly used matrices in biological and clinical 
studies. Plasma and serum are derived from full blood the difference is the process to 
obtain them; to obtain plasma is necessary to add an anticoagulant such as EDTA 
(Ethylenediamine tetraacetic acid) or heparin before the removal of blood cells. For serum 
it is necessary the coagulation of the blood and after that the process of centrifugation 
leads to the release of proteins and metabolites into the serum by the platelets. One study 
showed that reproducibility was significantly better for plasma than for serum which may 
result from the less complicated collecting procedure for plasma, as it does not require 
time to coagulate.  In terms of metabolite concentrations it was observed to be higher in 
serum and the sensitivity is also higher in the serum. [61] 
Serum or plasma infrared spectroscopy analyses are very useful in diagnosing and 
monitoring a great diversity of disorders. If the concentrations are high enough MIR 
spectra can distinct these six organic species, glucose, total protein, albumin, triglycerides, 
urea and cholesterol. The MIR region gives a “fingerprint” characteristic of molecular 
species, like mentioned before is the region that gives more information.  In plasma FTIR 
spectrum it is possible to observe the peaks associated to its constituents because each 
biomolecule have its own structure and it will exhibit a unique FTIR spectrum with more or 
less specific absorption peaks. To determine the absorption spectra of some biomolecules 
it is necessary to subtract the absorption spectra of others, one example is the case of 
lactate; to see the absorption pattern of lactate it is necessary to subtract the absorption 
attributable to glucose first. [58, 62] 
 A study that compared the results of 35 plasma FTIR spectra revealed that albumin 
was the biomolecule present in the highest concentration in plasma; albumin represents 
65% of plasma proteins and 45% of the total plasma mass. [58] 
One problem of IR spectroscopy is that water is the most abundant species found 
in all biological fluids, and that can interfere with the IR spectra. [62] 
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1. METHODS OF STUDY 
 
1.1. Study group 
According to previous works the inclusion criteria for the present study group 
were: age between 50-90 years, resident in Aveiro region, with complaints including 
objective memory impairment or other cognitive complains. In contrast the excluding 
criteria contain individuals undergoing chemotherapy or radiotherapy, suffering from 
psychiatric illness (e.g. bipolar disease, schizophrenia), or using illicit drugs. [63, 64] 
Sample collection and cognitive evaluation of individuals was carried out at several 
centres for primary health care from Aveiro region.   
The project was approved by the ethics committee of the Regional Health Centre - 
Coimbra, protocol number 012 804 of April 4, 2012.  
The cognitive tests applied to the study group were: Clinical Dementia Rating scale 
(CDR), Mini-Mental State Examination (MMSE) and Geriatric Depression Scale (GDS).  
In this study cognitive dysfunction was considered when CDR ≥ 0.5. The CDR scale 
is: 
 0:  normal function; 
 0.5: transition level (questionable dementia); 
 1.0: significant loss (almost always a clear correlation with dementia); 
 2.0: loss of moderate cognitive function; 
 3.0: severe loss. 
MMSE is a test that allows patient stratification according to the education level: 
 Cutoff of 22 for 0-2 years schoolarship; 
 24 for 3-6 years; 
 27 for more than 7 years. 
The GDS scale is a test with 15 questions that allowed exclusion from the study of 
depressed individuals. 
According to cognitive evaluation, 45 individuals were subdivided in 3 groups: the 
age and sex matched control group, presenting negative result for all the 3 cognitive tests; 
the putative AD group, with a positive result for CDR and MMSE scales but negative for 
GDS and other neuropathologies; the other neuropathologies group, which includes 
subjects suffering from other pathologies or mixed disorder and thus also positive on CDR 
and MMSE scales. It was also reunited other clinical data related to presence of some AD 
risk factors, namely the manifestation of comorbidities such as DM, dyslipidaemia or 
hypertension (HTN). Samples identification is in table 4.  
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Table 4| Characterization of study samples group according to sex, age and cognitive evaluation. 
COD Sex Age MMSE CDR Condition 
C1J F 65 - - Control 
C2J F 81 - - Control 
C3J F 78 - - Control 
C4J F 65 - - Control 
C5J F 72 - - Control 
C6J F 72 - - Control 
C7J F 78 - - Control 
C8J F 73 - - Control 
C9J M 82 - - Control 
C10J F 81 - - Control 
C11J M 74 - - Control 
C12J F 49 - - Control 
C13J F 75 - - Control 
C14J F 84 - - Control 
C15J F 75 - - Control 
C16J M 78 - - Control 
C17J F 75 - - Control 
C18J F 72 - - Control 
C19J F 77 - - Control 
C20J F 75 - - Control 
C21J M 81 - - Control 
C22J M 82 - - Control 
C23J F 80 - - Control 
C24J F 79 - - Control 
C25J F 72 - - Control 
D1J M 80 + - Putative AD 
D2J F 65 + - Putative AD 
D3J F 84 + + Putative AD 
D4J F 74 + + Putative AD 
D5J F 49 + + Putative AD 
D6J M 83 + + Putative AD 
D7J F 74 + + Putative AD 
D8J F 72 + + Putative AD 
D9J M 74 + + Putative AD 
D10J F 78 + + Putative AD 
D11J F 85 + + Putative AD 
D12J F 78 + + Putative AD 
D13J F 76 + + Putative AD 
D14J F 82 + + Putative AD 
D15J F 86 + + Putative AD 
D16J M 80 + - Putative AD 
D17J F 88 + + Putative AD 
D18J F 80 + + Putative AD 
D19J F 76 + + Other/mixed dementia 
D20J F 76 + + Other/mixed dementia  
 
 
35 
 
1.2. Analysis conditions 
To the present study it was necessary to make some optimization in the method. 
The optimization in the sample collection, in the FTIR spectral acquisition and with a drying 
process was according to previous works, “Identification of Alzheimer biomarkers by FTIR 
– a pilot study” and” Identification of potential Alzheimer’s disease biomarkers in plasma 
using FTIR”. [63, 64] 
To obtain the plasma aliquots of the samples, it was used it was used tubes K2 
EDTA 5 mL with gel separator and then it was applied a centrifugal force of 1800g during 
15 minutes at 8ºC. After this process the blood cells were separated from plasma. The 
plasma aliquots performed were of 30 μL and they were stored at -80 ºC. In this work the 
spectrometer used to acquire the spectra was Perkin-Elmer Spectrum BX FT-IR™. The 
spectra were obtained in a range of 4000-600 cm-1, at resolution of 8 cm-1, with 64 co-
added scans. For each sample 8 μL of plasma were used. 16 spectra were acquired, that 
corresponds to 40 minutes, which is the estimate drying time. During all the process the 
room temperature and humidity were maintened at ± 23ºC and ± 39%, respectively. 
This work it is a continuation of two previous works, [63] and [64]. Like mentioned 
before, with this work it is intended to confirm some hypotheses of those previous studies 
and to confirm the location of the samples on the scores diagram (reproducibility). For 
that spectra of 3 samples existing in larger quantities were repeated and their location in 
scores diagram were compared with the location of spectra acquired previously.  
Three spectral regions were analysed, 3500-2700 cm-1, 1800-1400 cm-1 and 1200-
900 cm-1. 16 spectra were obtained for each sample and in the previous works has been 
used only the last 3 in the analysis. In this work it was used only the last two since it was 
observed that the spectrum 14 still had water. As can be observed in figure 7 the spectra 
are different under the 900 cm-1 region which, indicating that they have different amounts 
of water. The region under 900 cm-1 is not used in multivariate spectra analysis but the 
presence of water also affects different spectral regions and can therefore affect the 
results. The multivariate analysis was repeated with this reduced data-set.  
 
Figure 7| All 14 spectrum, showing that it still had water 
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1.3. Main MIR regions of interest for study aims 
 
It is possible to divide the MIR region in other smaller spectral regions where 
strong absorption bands can be associated to specific components (figure 8). Those 
regions are: fatty acids region; amide region, ascribed primarily to proteins and peptides; 
mixed region, ascribed to carboxylic groups of proteins, free amino acids and 
polysaccharides; and the polysaccharide region. Besides, there are others spectral regions 
such as the one that is relevant to RNA, DNA and phospholipid content. [76] 
The 900-600 cm-1 region can be called the “true fingerprint region” because it 
shows a range of weak but extremely characteristic features. Some bands that can be 
observed in this region are bands arising from aromatic ring vibrations of phenylalanine, 
tyrosine, tryptophan, and the various nucleotides. [77]
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Figure 8| FTIR example spectra with main regions of FTIR spectra in a range of 4000-600 cm
-1
. 
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2. RESULTS AND DISCUSSION 
2.1. Localization of the new samples 
 In this study three samples were repeated, and new spectra of those samples were 
acquired. After that, the spectra were joined to the previous “data set” and new 
multivariate analyses were made. The following images (figure 9-14) are related to results 
obtained by comparing the location of samples that were repeated in this study with the 
ones of the previous studies. It is possible to see that their location is very similar, the new 
spectra are very close to the previous ones. 
 With these results it is possible to say that the results of multivariate analysis are 
reliable and that the classification models are robust. The results also showed that the 
frozen samples at -80 ° C didn´t suffer significant changes.  
 
Figure 9| PCA scores scatter plot of 3500-2700 cm
-1
 spectral region showing the location of the repeated samples 
 
Figure 10| PCA loadings of 3500-2700 cm
-1
 spectral region  
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Figure 11| PCA scores scatter plot of 1800-1400 cm
-1
 spectral region showing the location of the repeated samples 
 
 
Figure 12| PCA loadings of 1800-1400 cm
-1
 spectral region  
 
1682 
1650 
1638 
1542 
1490 
1472 
1408 
1664 
1623 
1588 
1560 
1544 1520 
1510 
1458 
40 
 
 
Figure 13| PCA scores scatter plot of 1200-900 cm
-1
 spectral region showing the location of the repeated samples 
 
 
Figure 14| PCA loadings of 1200-900 cm
-1
 spectral region  
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2.2. Spectral analysis 
The obtained spectra were analyzed to identify the maximum wavenumber peaks 
at both control and disease samples. Each of these spectral signals have one or more 
assignment (specific type of molecular vibration), that corresponds to a certain chemical 
group or a chemical family of compounds. This will help in the identification of the main 
chemical components of the plasma samples (table 5).  
Table 5| Spectral assignments of plasma and serum samples. 
Peaks 
(cm
-1
) 
Assignments Plasma contents Ref. 
≈ 3718 O-H stretching and an intermolecular  
vibration of CO2 and phenol** 
Presence of gaseous CO2  [42] 
≈ 3454 N-H stretching Proteins (amide A) [43] 
≈ 3286 N-H stretching, H-O-H symmetric and 
asymmetric stretching*  
Proteins (amide A) [44], [45] 
≈3282 N-H stretching Proteins (amide A) [65], [66] 
≈ 3190 N-H symmetric stretching mainly cis-ordered sub-structures [26] 
≈3088 N-H stretching Proteins (amide B) [65], [66] 
≈ 3052 N-H stretching Proteins (amide B) [26] 
≈2966 C-H asymmetric stretching of CH3 
group 
Lipids (cholesterol esters, 
triglycerides) 
[67], [68], 
[69] 
≈ 2962 C-H asymmetric stretching of CH3 
group* 
Lipid acyl chains in lipid bilayers 
(phospholipids) 
[29], [44], 
[46], [47] 
≈2944 C-H asymmetric stretching of CH2  
group 
Lipids (long chain fatty acids, 
phospholipids) 
[67], [68], 
[69] 
≈ 2938 C-H stretching of CH2 and CH3 group* Fatty acids [29], [43], 
[44] 
≈ 2878 C-H symmetric stretching of CH3 
group* 
Lipid acyl chains in lipid bilayers 
(phospholipids) 
[29], [44], 
[46], [47] 
≈2872 C-H symmetric stretching of CH3 group Lipids (long chain fatty acids, 
phospholipids) 
[67], [68], 
[69] 
≈1750 C=O symmetric stretching Lipids (cholesterol esters, 
triglycerides) 
[67], [68] 
≈ 1740 C=O stretching Fatty acid esters (triglycerides), 
lipid bilayers (phospholipids) 
[23], [44], 
[46] 
≈ 1716 C=O stretching Carbonic acid, phospholipid sub-
structures, purine bases from 
nucleic acids 
[23], [29], 
[44], [48] 
≈ 1638 C=O stretching*;  
NH3
+
 asymmetric in plane bending 
(rocking)* 
Proteins (amide I for β-sheet); 
Membrane lipids (phospholipids) 
[29], [44], 
[47], [49] 
≈ 1636 C=O stretching and N-H in plane 
bending 
Proteins (amide I) [70], [71] 
≈ 1536 N-H bending in plane, C-N stretching* Proteins (amide II) [29], [44], 
[45] 
≈ 1516 N-H in plane bending and C-H 
stretching 
Proteins (amide II) [70], [71] 
≈ 1512 CC (phenyl ring) stretching, CH in plane 
bending*  
tyrosine band (proteins side chain)  [29], [44], 
[50] 
≈ 1474 C-H asymmetric bending of CH2 group / 
C-H bending of CH2 group 
Lipids (fatty acids, phospholipids, 
triglycerides) 
[67], [68], 
[69] 
≈ 1470 CH2 bending;  
C-H asymmetric bending;  
Proteins; 
Carbohydrates;  
[23], [26], 
[29], [47] 
42 
 
CH2 symmetric in plane bending 
(scissoring)* 
Lipid acyl chains in lipid bilayers 
(phospholipids) 
≈ 1454 C-H asymmetric bending of CH2 group / 
C-H bending of CH2 group 
Lipids (fatty acids, phospholipids, 
triglycerides) 
[67], [68], 
[69] 
≈ 1452 CH2 bending and CH3 asymmetric in 
plane bending (rocking)*; 
C-O symmetric stretching 
Proteins, membrane lipids 
(phospholipids); 
Carbohydrates 
[23], [26], 
[46], [47] 
≈ 1402 COO stretching Amino acids side chains [67], [72] 
≈ 1398 C=O symmetric stretching of COO
-
 
group, C-O symmetric stretching*; 
C-O bending (carboxylate ions)*; 
CH3 and N
+
(CH3)3 symmetric bending* 
Proteins and carbohydrates; 
Mixed region (carboxylic groups); 
Membrane lipids (phospholipids) 
[23], [45]–
[47] 
≈ 1342 CH2 wagging***
 
Collagen [73], [74], 
[75] 
≈ 1338 CH2 wagging*  Membrane lipids (phospholipids) [45], [47] 
≈ 1320 C-O stretching Carbohydrates [23] 
≈ 1301 N-H bending and C-N stretching  Proteins (amide III) [70], [71] 
≈ 1290 N-H bending in plane, C-N stretching*; 
C-O stretching; 
N-H thymine/cytosine deformation 
Proteins (amide III); 
Carbohydrates; 
Nucleic acids  
[23], [26], 
[44], [45] 
≈ 1246 N-H bending and C-N stretching Proteins (amide III) [70], [71] 
≈ 1242 N-H bending in plane, C-N stretching*; 
P=O asymmetric stretching of PO2
-
 
group 
Proteins (amide III, mainly α-helix 
conformation); 
Phosphodiester groups of nucleic 
acids 
[26], [44], 
[45] 
≈ 1168 Ester and CO-O-C antisymmetric 
stretching*;  
C-O, C-C stretching and C-O-H, C-O-C 
deformation* 
Membrane lipids (phospholipids); 
Carbohydrates 
[44], [45], 
[47] 
≈ 1115 C-O, C-C stretching, C-O-H, C-O-C 
deformation and C-O-C asymmetric 
stretching*; 
P-O-C symmetric stretching, C-O 
stretching of C-OH group 
Carbohydrates;  
Phosphodiesters, RNA 
[23], [26], 
[44] 
≈ 1077 C-O, C-C stretching, C-O-H, C-O-C 
deformation and C-O-C asymmetric 
stretching*; 
PO2
-
, CO-O-C symmetric stretching*; 
Carbohydrates; 
Membrane lipids (phospholipids) 
and nucleic acids sugar backbone  
 
[23], [26], 
[44], [47] 
≈ 1032 C-O, C-C stretching, C-O-H, C-O-C 
deformation*; 
C-O symmetric stretching 
Carbohydrates; 
Nucleic acids sugar backbone 
[23], [26], 
[44] 
≈ 994 C-O ribose, C-C*** Ribose [73], [74], 
[75] 
≈ 987 C-O, C-C stretching, C-O-H, C-O-C 
deformation, C-H bending*; 
CH3-N asymmetric stretching 
Carbohydrates; 
Membrane lipids (phospholipids) 
[23], [44] 
≈ 924 C-O, C-C stretching, C-O-H, C-O-C 
deformation*; 
N
+
(CH3)3 symmetric stretching*  
Carbohydrates; 
Membrane lipids (phospholipids) 
[44], [47] 
*Characteristic band assignments of biological samples (not specific for plasma) 
**Not characteristic of biological samples 
***Only present in plasma 
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The spectral band at 3718 cm-1 might be related to a higher level of plasma acidity, 
which is usually found at perturbations of acid/base blood balance mechanisms that in 
turn might be associated to presence of general oxidative stress responses. In acidic 
conditions such as brain ischemia and hypoxia, I2 PP2A (inhibitor-2 of protein 
phosphatase-2A) is cleaved into a C-terminal and an N-terminal fragments that are known 
to bind to PP2A (protein phosphatase-2A) catalytic subunit inhibiting its activity. Once, 
that a decrease in PP2A can be a cause of the protein tau abnormal hyperphosphorylation 
in AD, it might be possible the involvement of brain acidosis in AD pathogenesis. [78] 
The peptide bond could exhibit nine characteristic IR-active amide bands (A, B and 
I-VII). Nonetheless, at the present study only amide A, B and I-III were identified in FTIR 
spectrum. The N-H stretching vibration gives rise to the amide A band between 3310 and 
3270 cm-1, it is exclusively localized on the NH group and is therefore insensitive to the 
conformation of polypeptide backbone. The amide A band is usually part of a Fermi 
resonance doublet with the second component absorbing weakly between 3100 and 3030 
cm-1 (amide B). Amides I and II, as mentioned below (2.2.2), are the major bands in the 
protein FTIR spectrum, with amide I providing the most insight into secondary structure. 
Amides III and IV are very complex bands resulting from mixtures of several coordinate 
displacements. Out-of-plane motions could be found in amides V, VI and VII. Given the 
technical and theoretical limitations, only amide bands I, II and III are used for analysis of 
protein secondary structure. [43, 45] 
It is believed that in neurodegenerative disorders there is significant lipid damage 
in brain tissues. In FTIR spectrum, lipids have characteristic C-H stretching vibrations 
between 3025 and 2700 cm-1. For –CH2 functional group, the asymmetric and symmetric C-
H stretching vibrations are found at ≈2920 and 2850 cm-1, respectively and for -CH3 
functional groups are found at ≈ 2957 and 2872 cm-1, respectively. In addition, unsaturated 
olefinic C=C-H stretching vibration has a unique vibrational frequency of 3012 cm-1. [48, 
79] 
The presence of a carbonyl group in a compound can be identified by the strong IR 
band at the region 1650-1850 cm-1, which corresponds to the C=O stretching vibration. At 
the present study, FTIR spectra analysis reveals some peaks in this region (1740, 1716 and 
1638 cm-1), which might be related to lipid hyperoxidation, especially 1740 cm-1 band. 
Indeed, the 1638 cm-1 band corresponds to β-sheet of amide I, which can be related to 
conformational changes of protein α-helices. [80] 
Tyrosine is a relative strong infrared absorber due to its polar character and the 
ring mode near 1517 cm-1 is one of its most intensive bands. [50] 
In relation to nucleic acid biochemistry, in a FTIR spectra the most characteristic 
findings are the C=O stretching vibrations from the purine (1717 cm-1) and pyrimidine 
(1666 cm-1) bases, besides antisymmetric (1224 cm-1) and symmetric (1087 cm-1) PO2- 
stretching vibrations at the 1500-1000 cm-1 region. [48] 
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In AD there are also some changes in the tertiary structure at the 780-739 cm-1 
spectral range. [35] 
 The next step was to apply a method of multivariate analysis for all 45 samples in 
the four different spectral regions 3500-2700 cm-1,  1800-1400 cm-1 and 1200-900 cm-1. 
The presented results correspond to the multivariate analysis obtained without the 14 
replicate, that, as mentioned before, presents high amount of water. 
2.3. PCA analysis and identification of main sample groups 
 It was possible to cluster the samples in some sub-groups, within control and 
putative AD groups, through the analysis of the scores and loadings obtained by PCA 
methodology. 
2.3.1. Spectral range of 3500-2700 cm-1 
In this spectral range (figure 15) it is possible to observe the presence of lipids (e.g. 
saturated or unsaturated), especially fatty acids and phospholipids, and its implications for 
cognitive health and dementia states. Besides, some information of amide A and B regions 
of proteins could be found in this range. 
 
Figure 15| Representative spectral region of 3500-2700 cm
-1
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Figure 16| PCA scores scatter plot of 3500-2700 cm
-1
 spectral region showing PC1 vs. PC2. C: control samples; D: 
dementia/cognitive impairment samples 
 
 
Figure 17| PCA loadings of 3500-2700 cm
-1
 spectral region showing the main maximum wavenumber peaks. 
Figure 16 shows that is possible to discriminate control samples that the great part 
of them are located in PC1. However disease samples are present in all quadrants, but 
mainly concentrated in negative PC1 region. 
Indeed, PCA loadings (figure 17) analysis turns possible to divide disease samples 
into two distinct groups, according to the presence of different kinds of molecular 
alterations (Table 6). Besides, disease samples present at positive PC1 express a more 
disperse distribution among control samples group. 
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There are some factors that can influence the results, such as: the presence of 
comorbidities, disorder of mixed nature, medication, or even factors as age or sex of the 
subjects. 
Table 6| Assignments of the main maximum peaks from PCA loadings (range of 3500-2700 cm
-1
). 
Peak (cm-1) PCs Assignment 
3400  PC1 (+)  N-H stretching of amide A  
3286 PC1 (-)  
PC2 (+) 
N-H stretching of amide A 
3172 PC1 (-)  
PC2 (-) 
O-H stretching band of carboxylic acids 
3070 N-H stretching of amide B 
3026 N-H stretching of amide B 
2952 PC1 (-)  
PC2 (+) 
C-H asymmetric stretching of -CH3 (fatty acids) 
2926 C-H asymmetric stretching of -CH2 (fatty acids) 
2884 C-H asymmetric stretching of -CH2 (membrane lipids) 
2864 C-H symmetric stretching of -CH3 (membrane fatty acids) 
2850 C-H symmetric stretching of -CH2 (membrane fatty acids) 
 
The spectral region between 4000-3100 cm-1 can give information resulting from  
O-H stretching modes (≈3400 cm-1) and from N-H stretching vibrations (amide A and amide 
B) and the region between 3100 and 2800 cm-1 gives information resulting from C-H 
stretching vibrations of –CH3 and –CH2 functional groups. [29] 
In the region with mainly disease samples it wasn´t detected any peak close to 
3012 cm-1, which could indicate very low content of unsaturated lipids. These results 
corroborate the fact that significant low levels of PUFAs in brain tissue are usually related 
to AD condition. [48, 79] 
In the region between 3025-2800 cm-1 it was possible to identify several peaks 
such as 2952 cm-1, 2926 cm-1, 2884 cm-1, 2864 cm-1 and 2850 cm-1, associated with the 
presence of saturated lipids. Alterations in this spectral range, mainly CH2 stretching 
vibrations, can indicate changes in the lipid order of the biological system. A high content 
of saturated lipids is related to some vascular perturbations that are strong correlated with 
higher risk of dementia development. [47, 48, 53, 80] 
Due to these results it can be said that there is an unbalance between the content 
of saturated and unsaturated lipids, favoring the first one. 
It was also seen a strong band at 3172 cm-1 that is related to strong O-H stretching 
vibrations, which is an evidence that it is essentially characterized by carboxylic acids. The 
presence of carboxylic compounds can be related with protein structural and functional 
disturbances in the neurodegeneration process and with changes in protein conformation, 
which will lead to a different localization of amide B region. [48, 53, 80, 81] 
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The PC1 positive region is composed mainly of control samples it can be seen also 
some dispersed disease samples inside its frontiers. The region with mainly control 
samples is characterized by the presence of assignment for amide A related to the peak 
3400 cm-1. [45] 
The fact of some controls are at negative PC1 indicates that these samples could 
present similar biochemical pattern to the disease samples. This means that those controls 
could have a higher risk of developing dementia or it can show the presence of cognitive 
impairment in a pre-clinical stage. 
2.3.2. Spectral range of 1800-1400 cm-1 
The spectral range 1800-1400 cm-1 (figure 18) is mainly related to protein 
conformation mode trough analysis of protein secondary structure (amide I and II) but also 
to chemical properties of nucleic acids bases, fatty acids and carbohydrates. 
 
Figure 18| Representative spectral region of 1800-1400 cm
-1
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Figure 19| PCA scores scatter plot of 1800-1400 cm
-1
 spectral region showing PC2 vs. PC3. C: control samples; D: 
dementia/cognitive impairment samples. 
 
 
Figure 20| PCA loadings of 1800-1400 cm
-1
 spectral region showing the main maximum wavenumber peaks. 
 
According to figure 19 is possible to say that the majority of dementia subjects 
have negative PC3 value and the control samples have mainly positive PC3, though there 
are also some controls in Q4. The main maximum peaks from PCA loadings are present in 
table 7. 
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Table 7| Assignments of the main maximum peaks from PCA loadings (range of 1800-1400 cm
-1
). 
Peak (cm-1) PCs Assignments 
1682  PC3 (+) C=O guanine deformation N-H in plane; unordered random coils, turns 
and loops (amide I) 
1664 PC2 (+) C=O band of α-helical structure (amide I)*, turns and loops 
1650 PC2 (+) C=O symmetric stretching band of α-helical structure  
(amide I) 
1638 PC3 (+) C=O stretching band of parallel β-sheet (amide I) 
1623 PC3 (+) C=O stretching band of parallel β-sheet (amide I) 
1588 PC3 (-) N-H bending in plane and C-N stretching (amide II); benzene ring 
vibrations from arginine 
1582 PC3 (-) C=N imidazole ring stretching (nucleic acids); benzene ring vibrations 
from arginine 
1576 PC3 (-) N-H bending in plane and C-N stretching (amide II);  
NH3
+
 symmetric bending (membrane lipids);  
C=N imidazole ring stretching (nucleic acids) 
1560 PC2 (+) N-H bending in plane and C-N stretching of amino acids (amide II); CO2- 
asymmetric stretching from glutamic acid 
1554 PC2 (+) N-H deformation mode of α-helical band (amide II)*;  
CO2- asymmetric stretching from glutamic acid 
1542 PC2 (+) N-H bending in plane and C-N stretching of amino acids (amide II) 
1520 PC2 (-)  
PC3 (+) 
N-H bending in plane and C-N stretching of amino acids (amide II); 
1510 PC2 (-)  
PC3 (+) 
N-H bending in plane and C-N stretching of amino acids (amide II); C-H 
in plane bending of phenyl rings (tyrosine) 
1490 PC2 (-)  
PC3 (+) 
N+(CH3)3 asymmetric bending (membrane lipids) 
1472 PC2 (-)  
PC3 (+) 
CH2 scissoring of proteins and CH3 scissoring of phospholipids 
(membrane lipids) 
1464 PC3 (-) CH2 scissoring and CH3 scissoring and asymmetric bending of 
phospholipids (membrane lipids) 
1458 PC3 (-) C=O symmetric stretching of COO- of amino acid side chains; CH2 
bending of mainly fatty acids (membrane lipids) 
1408 PC3 (-) C=O symmetric stretching of COO- of amino acid side chains and fatty 
acids; N+(CH3)3 symmetric bending (membrane lipids) 
*related to structural analysis of synthetic polypeptide 
Amide I (1600-1700 cm-1) and amide II (1500-1560 cm-1) bands are two prominent 
features of a typical protein spectrum, the first is due to C=O stretching vibration and the 
second to the N-H bending and C-N stretching vibrations of peptide backbone. The 
frequency of amide I band is particularly sensitive to secondary structure what makes FTIR 
a valuable technique for evaluating protein aggregation at neurodegenerative disorders. 
[43, 48] 
Two important factors in degenerative disorders are oxidative stress and free 
radical damage. As a result, it is not surprising that there is a decreased intensity of 1455 
cm-1 centered peak (Table 7), which is close to the 1458 cm-1 peak identified at the present 
study (Figure 20). This results from deformation and stretching vibrations of CH2 groups 
particularly in fatty acids (present in membrane lipids). [38, 48] 
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The 1582 cm-1 band might be associated to alteration of conformational state and 
structural stability of nucleic acid molecules. The same may also be stated for 1576 cm-1, to 
which is added structural changes in lipids. Altered protein conformation and presence of 
protein aggregates typical of AD lead to different localization for amide II that can be seen 
in 1588 cm-1 peak. 1464 cm-1 and 1408 cm-1 peaks are due mainly to structural changes of 
associated membrane lipids, namely fatty acids and phospholipids. [44, 45, 47, 53] 
Almost all of patients that belong to AD group present comorbidities, which may 
be translated in higher severity and faster progression of the disease condition. 
In the control samples the identified 1520 cm-1 and 1510 cm-1 peaks are associated 
with unaltered protein conformation, without any signal that could indicate protein 
aggregation or presence of intermediate damaging forms like oligomers. These results are 
in accord with the biochemical pattern of a control sample. [43, 49] 
The other peaks 1472 cm-1 and 1490 cm-1, are associated to structural properties of 
membrane lipids. The 1490 cm-1 peak is particularly connected to membrane injury 
probably due to the action of oxidative stress and free radicals inductors of cell damage. 
The presence of some comorbidities such as DM and HTN helps the development of 
dementia and/or some other related neurodegenerative diseases. Once the subjects of 
this group suffer from those comorbidities it is possible that these subjects had already 
achieve the pre-MCI or initial phase of MCI state and it would be important theirs clinical 
monitoring.  
The peaks 1682 cm-1, 1638 cm-1, 1623 cm-1 observed in control samples could be 
associated to the disease samples present in it, because of their coordinates and their 
match to amide I region of aggregated proteins (Figure 12). Indeed, 1623 cm-1 peak had 
been considered as characteristic of a protein in an aggregated state, during FTIR analysis 
of cerebral tissue from AD patients. [43, 48, 82] 
Contrarily to fibrils, oligomers present both 1630 and 1695 cm-1 peaks, which 
correspond to an anti-parallel β-sheet conformation. In the present study 1695 cm-1 peak 
is not present loadings (Figure 13), but it doesn´t mean the complete lack of oligomer 
forms in the analyzed samples, and there is two peaks near to 1630 cm-1 (i.e. 1623 cm-1 
and 1638 cm-1), which is related to highly stable parallel β-sheet that in turn is usually 
associated to the presence of fibrils. A higher proportion of Aβ fibril forms is related to a 
later stage of the disease once it is believed that Aβ soluble oligomers are an intermediate 
form that precedes Aβ fibrils. The fact of the absence of 1695 cm-1 peak, suggested that Aβ 
fibrils are present in higher content than Aβ oligomers. [83] 
Most of the proteins present a mixture of secondary structures, and thus, the 
amide I band represents a combination of these components. The 1670-1685 cm-1 region 
is related to the presence of non-β structure in protein fibrils, especially turns and loops, 
so, Aβ fibrils present in lower content non-β structures related mainly to 1682 cm-1 band. 
Amorphous aggregates also may present a spectral band at 1623 cm-1, and they are not 
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associated to a higher content of β-sheet structure, contrarily to protein fibrils. The 
presence of a band at 1623 cm-1 (Figure 20), might indicate that besides protein fibrils 
there are also some amorphous aggregates, arising from a relatively unfolded-like partially 
folded and a native like conformation, respectively. [43, 48, 82] 
Components of C=O band with α and β forms are related to spectral peaks at 1658 
cm-1 and 1629 cm-1, respectively, thus the 1664 and 1623 cm-1 peaks found in the present 
study are related to α and β forms. In addition, the identified peaks at 1554 and 1542 cm-1 
that are linked to N-H deformation mode, because N-H deformation mode corresponds to 
a signal peak at 1550 cm-1. [43] 
In the other hand, control samples could be associated to signal peaks identified at 
1664 cm-1 and 1650 cm-1 that are related to the typical localization of amide I of proteins 
mainly constituted by α-helix structures. This is corroborated by protein structural 
information given by 1560 cm-1, 1554 cm-1, 1542 cm-1 and 1538 cm-1 peaks. Nevertheless, 
giving the proximity of these samples to the disease ones, from both Q1 (protein 
aggregates) and Q4 (lipid and nucleic acids altered biochemistry), it is possible that control 
samples share some biochemical characteristics with disease samples. Therefore, it is quite 
plausible that control subjects have already been suffering with a pre-clinical form of 
cognitive impairment (i.e. beginning of MCI). [43, 44, 45, 84] 
2.3.3. Spectral range of 1200-900 cm-1 
The spectral region 1200 - 900 cm-1 is usually dominated by the symmetric 
stretching of PO2 groups in nucleic acids and a complex sequence of peaks due mainly to 
strongly coupled C-C, C-O stretching and C-O-H, C-O-C deformation modes of several 
oligosaccharides . Besides oligosaccharides and nucleic acids structural and functional 
information, it is possible to identify signal peaks related to membrane lipids. 
 
Figure 21| Representative spectral region of 1200-900 cm
-1
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Figure 22| PCA scores scatter plot of 1200-900 cm
-1
 spectral region showing PC1 vs PC2. C: control samples; D: 
dementia/cognitive impairment samples 
 
 
Figure 23| PCA loadings of 1200-900 cm
-1
 spectral region showing the main maximum wavenumber peaks. 
 
The PCA scores in the figure 22 showed that is possible to identify some disease 
samples localized, at positive PC1 and some at negative PC1.  
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Table 8| Assignments of the main maximum peaks from PCA loadings (range of 1200-900 cm
-1
). 
Peak (cm-1) PCs Assignment 
1168  
 
PC1 (+)  
 
C-O stretching of ribose from nucleic acids;  
CO-O-C asymmetric stretching (membrane lipids) 
1122 PO stretching of phosphodiester backbone and C-O 
stretching of deoxyribose and ribose (nucleic acids) 
1090 PO2- symmetric stretching of sugar rings (nucleic acids) and 
membrane lipids 
1078  
 
 
 
 
 
 
 
 
 
PC1 (-) 
CO-O-C symmetric stretching (membrane lipids) 
1062 Ester C-O-C symmetric stretching (phospholipids); ribose C-
O stretching (nucleic acids) 
1048 C-O stretching of sugar rings (nucleic acids) 
1034 C-N symmetric stretching of amino acid (aliphatic amines); 
ribose C-O stretching (RNA) 
1018 C-O stretching in osidic and protein structures; symmetric 
stretching of dianionic phosphate monoester (nucleic acids, 
especially DNA) 
1002 C-O stretching in osidic and protein structures; uracil ring 
bending (RNA); symmetric stretching of dianionic 
phosphate monoester (nucleic acids, especially DNA) 
988 C-O stretching in osidic and protein structures; symmetric 
stretching of dianionic phosphate monoester (nucleic acids, 
especially DNA) 
974 C-O stretching in osidic and protein structures; N
+
(CH3)3 
asymmetric stretching (membrane lipids); symmetric 
stretching of dianionic phosphate monoester (nucleic acids, 
especially DNA) 
958  
 
 
PC1 (+) 
C-O stretching in osidic and protein structures; symmetric 
stretching of dianionic phosphate monoester (nucleic acids, 
especially DNA) 
930 C-O-H out of plane bending of carboxylic acids; C-O 
stretching in osidic and protein structures; symmetric 
stretching of dianionic phosphate monoester (nucleic acids, 
especially DNA) 
 
The disease samples are distributed among PC1 region, having less contribute of 
PC2, which makes difficult to distinguish the wavenumber components of each sample. 
Consequently, like it is possible to see in table 8, the analysis of main maximum peaks in 
PCA loadings doesn´t allow differentiating clearly the biochemical pattern between the 
disease samples groups, once that the alterations present in both are in the majority in 
nucleic acids, but also in membrane lipids and proteins. It is not also possible to distinguish 
the control groups by PCA loadings because it has not been identified spectral bands that 
could be related to control characteristics. 
Although it is possible to see that disease samples  seems to have more contribute 
from negative PC1 signal peaks and on contrary the control samples presents more 
contribution from positive PC1 signal peaks. Which may be inferred from that information 
is that those two groups have contrasting biochemical characteristics, which could 
translate in opposing clinical profiles. 
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It is possible to relate the presence of hydroxyl compounds (products of lipid 
peroxidation and have already been reported as markers of oxidative damage in AD), with 
the C-O stretching bands found in the 1150-1000 cm-1 spectral region. In the 1200-1100 
cm-1 region it is possible to see saturated lipids (aliphatic esters), which can lead to a 
higher content of saturation and consequently to a higher risk of membrane damage and 
vascular events. The disease individuals can have a risk of a more severe picture of 
neurodegeneration because the majority of them have comorbidities such as DM, HTN or 
dyslipidaemia and it is known that hyperoxidation of lipids, phospholipids and membranes 
takes place during the atherogenesis process. [53, 80, 85] 
With the spectral peaks at 1122 cm-1, 1090 cm-1, 1048 cm-1, and the ones from the 
1020-930 cm-1 region it is possible to see that Nucleic acids molecules, especially DNA, 
represent a major target for free radicals when capacity of intracellular free radical 
scavengers and antioxidants is overcome. There are some repair enzymes systems that try 
to remove and replace the damaged nucleosides and repair the broken strands, but like it 
is possible to see by the high plasmatic levels of 8-OHdG (8-hydroxydeoxyguanosine) found 
in AD patient samples, the rate of DNA damage still be high. It is supposed that the 
accumulation of damages in DNA can contribute to progressive neuronal cell loss, since 
nonrepaired DNA damage can lead to programmed cell death. [38] 
 
3. CONCLUDING REMARKS 
With this work it is possible to affirm that the results obtained by FTIR and 
multivariate analysis are reliable and that the classification models are robust. When 
sample acquisition is repeated 12 months later principal components analysis (scores 
diagram) showed that the location of the new spectra is very close to the previous ones. 
Additionally the removal of all the spectra with deficient drying process (more moisture) 
improves results; the discrimination between putative AD and sex and age matched 
controls allows the identification of more defined groups. This means that some 
conditions, such as temperature and humidity, in the moment of the analyses will be 
crucial for the results and can influence them. The improvement of the discrimination 
between samples groups can be reflected, in the future, in the construction of robust 
classification models. 
With the modified data set it was possible to confirm previous results. With the 
direct analysis of spectra it is possible to recognize the main chemical FTIR assignments in 
plasma, which will help in creating a pattern of chemical vibrations and identify the 
principal spectral regions with important information. Although that advantage, it is 
necessary to use multivariate data analysis techniques, such as PCA, to draw out the 
significant and no redundant spectra information once biological samples are very 
complex, and direct analysis of spectra proved to be insufficient to distinguish between 
the spectra of control and dementia samples. 
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Some IR significant regions in which are possible to acquire spectrum data with 
important information are 3500-2700 cm-1 (lipids), 1800-1400 cm-1 (protein conformation) 
and 1200-900 cm-1 (carbohydrates and nucleic acids structure). In the lipids region the 
main conclusion that is possible to take is that there is an unbalance between the content 
of saturated and unsaturated lipids, favouring the first one which can lead to a high 
potential brain damage. It could be also seen the presence of carboxylic acids that are 
usually related to lipid hyperoxidation, production of reactive carbonyls and protein 
structural and functional disturbances. In relation to the second region (protein 
conformation) it was found the presence of protein aggregates and the change in protein 
conformation for highly stable parallel β-sheet, which is usually associated to the presence 
of Aβ fibrils. The 1200-900 cm-1 region showed the presence of products of lipid 
peroxidation related to impairment of membranes, and nucleic acids oxidative damage.  
There are some relevant clinical factors that could influence the results of this 
work, some of them are: the presence of several comorbidities in the majority of subjects, 
unknown and/or undiagnosed genetic predisposed factors, use of medication capable of 
affect biochemical plasma levels or the presence of a neurodegenerative disorder of mixed 
nature.  
Finally is possible to say that FTIR analysis can be used to build classification 
models that in the future can be used for cognitive impairment diagnosis or identification 
of disease stage and prognostic evaluation, besides assessment of disease developing risk 
for control subjects. However it is necessary further clinical trials that enlarge the data set 
with fully characterized sample. 
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